Cargando…

Discrepancies in the evaluation of the safety of the human papillomavirus vaccine

Despite being more than ten years since its introduction, global acceptance to the human papillomavirus (HPV) vaccine is still low. The immunogenetic background of the host, and HPV antigen recognition, are important in natural HPV infection, and should be taken into account in the understanding of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cervantes, Jorge L, Doan, Amy Hoanganh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Instituto Oswaldo Cruz, Ministério da Saúde 2018
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5967601/ https://www.ncbi.nlm.nih.gov/pubmed/29846395 http://dx.doi.org/10.1590/0074-02760180063

Ejemplares similares

Donor Safety, Discrepancies Between Practice and Theory: Analysis of the Polish Supreme Audit Office’s Report
por: Patryn, Rafał, et al.
Publicado: (2023)

Discrepancies in Data Reporting for Rabies, Africa
por: Nel, Louis H.
Publicado: (2013)

Monitoring Effect of Human Papillomavirus Vaccines in US Population, Emerging Infections Program, 2008–2012
por: Hariri, Susan, et al.
Publicado: (2015)

Human papillomavirus vaccination in the European Union/European Economic Area and globally: a moral dilemma
por: Colzani, Edoardo, et al.
Publicado: (2021)

Taking stock and looking ahead: Behavioural science lessons for implementing the nonavalent human papillomavirus vaccine
por: Forster, Alice S., et al.
Publicado: (2016)

Safety of human papillomavirus vaccines: a review
por: Stillo, Michela, et al.
Publicado: (2015)

A systematic discrepancy between the short circuit current and the integrated quantum efficiency in perovskite solar cells
por: Saliba, Michael, et al.
Publicado: (2023)

Evaluating Human Papillomavirus Vaccination Programs
por: Taira, Al V., et al.
Publicado: (2004)

Progress of Active Surveillance for Vaccine Safety in China
por: Liu, Zhike, et al.
Publicado: (2021)

The Importance of Active Surveillance in the Assessment of Vaccine Safety
por: Black, Steven
Publicado: (2019)

Comment on “Safety of Human Papillomavirus Vaccines: An Updated Review”
por: Chandler, Rebecca Ellen, et al.
Publicado: (2018)

Safety and Efficacy Data on Vaccines and Immunization to Human Papillomavirus
por: Kash, Natalie, et al.
Publicado: (2015)

Long-term efficacy and safety of human papillomavirus vaccination
por: De Vincenzo, Rosa, et al.
Publicado: (2014)

The Global Vaccine Safety Initiative: enhancing vaccine pharmacovigilance capacity at country level
por: Maure, Christine G, et al.
Publicado: (2014)

Who is Responsible for Evaluating the Safety and Effectiveness of Medical Devices? The Role of Independent Technology Assessment
por: Feldman, Mitchell D., et al.
Publicado: (2007)

Discrepancy of human papillomavirus vaccine uptake and intent between girls 9–14 and their mothers in a pilot region of Shanghai, China
por: Guo, Qi, et al.
Publicado: (2022)

Safety and Considerations of the COVID-19 Vaccine Massive Deployment
por: Li, Junwei, et al.
Publicado: (2021)

Potential Immunologic and Integrative Methods to Enhance Vaccine Safety
por: Dattner, Alan M.
Publicado: (2022)

COVID-19 vaccine safety surveillance and emerging concerns of vaccine-induced immune thrombotic thrombocytopenia
por: Teo, Shyh Poh
Publicado: (2021)

Extended surveillance to assess safety of 9-valent human papillomavirus vaccine
por: Sundaram, Maria E., et al.
Publicado: (2022)

Human papillomavirus vaccine
por: Singhal, Priyanka, et al.
Publicado: (2009)

Current status of Zika vaccine development: Zika vaccines advance into clinical evaluation
por: Barrett, Alan D. T.
Publicado: (2018)

Safety and immunogenicity of human papillomavirus vaccination in juvenile patients with rheumatic diseases
por: Heijstek, MW, et al.
Publicado: (2011)

A Broad Safety Assessment of the 9-Valent Human Papillomavirus Vaccine
por: Yih, W Katherine, et al.
Publicado: (2021)

Immunogenicity, efficacy, and safety of human papillomavirus vaccine: Data from China
por: Li, Mingzhu, et al.
Publicado: (2023)

Economic evaluation of human papillomavirus vaccination in the United Kingdom
por: Jit, Mark, et al.
Publicado: (2008)

Generalists' role in vaccine safety reporting
por: Welch, Thomas R.
Publicado: (2013)

Evaluation in Nonhuman Primates of Vaccines against Ebola Virus
por: Geisbert, Thomas W., et al.
Publicado: (2002)

Feng-Cai Zhu: leading vaccine evaluation in China
por: Kirby, Tony
Publicado: (2015)

COVID-19 vaccines: progress and understanding on quality control and evaluation
por: Mao, Qunying, et al.
Publicado: (2021)

Evaluating Functional Immunity Following Encapsulated Bacterial Infection and Vaccination
por: Toh, Zheng Quan, et al.
Publicado: (2021)

Vaccination Safety: Don’t Toss the Champagne With the Cork
por: Shah, Aditya, et al.
Publicado: (2021)

Knowledge about human papillomavirus and the human papillomavirus vaccine in Belgian students
por: Deriemaeker, Hanne, et al.
Publicado: (2014)

Pragmatic trial of an intervention to increase human papillomavirus vaccination in safety-net clinics
por: Sanderson, Maureen, et al.
Publicado: (2017)

Human Papillomavirus Vaccination Strategies
por: Cachafeiro, Santiago Pérez
Publicado: (2007)

Vaccination against human papillomavirus
por: Mello, Claudia Figueiredo
Publicado: (2013)

Human Challenge Studies to Accelerate Coronavirus Vaccine Licensure
por: Eyal, Nir, et al.
Publicado: (2020)

Introducing students to patient safety through an online interprofessional course
por: Blue, Amy V, et al.
Publicado: (2010)

Progress in Vaccination of Prophylactic Human Papillomavirus Vaccine
por: Zhou, Xu, et al.
Publicado: (2020)

Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus
por: Toh, Zheng Quan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mj8f4nu32jvfii2om5cpfsa3tg